Ayesha Zia Selected Research

Ayesha Zia Research Topics

Disease

8	Hemorrhage 11/2023 - 07/2013
6	Thrombosis (Thrombus) 11/2022 - 01/2020
4	Menorrhagia 01/2023 - 01/2020
3	Hemophilia A (Haemophilia) 11/2023 - 07/2013
3	COVID-19 01/2022 - 11/2020
3	Hemolysis 10/2020 - 10/2016
3	Thrombophilia 10/2020 - 08/2015
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2024 - 10/2020
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2024 - 10/2020
2	COVID-19 related pediatric multisystem inflammatory disease 01/2022 - 11/2020
2	Infections 01/2022 - 07/2013
2	von Willebrand Diseases (von Willebrand's Disease) 01/2022 - 01/2020
2	Neoplasms (Cancer) 01/2021 - 10/2016
1	Thrombocytopenia (Thrombopenia) 01/2024
1	Heart Valve Diseases (Valvular Heart Disease) 01/2023
1	Iron Deficiencies 01/2022
1	Fatigue 01/2022
1	Venous Thromboembolism 01/2022
1	Spontaneous Abortion (Miscarriage) 01/2022
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2022
1	Stroke (Strokes) 01/2021
1	Sickle Cell Anemia (Hemoglobin S Disease) 10/2020
1	Pain (Aches) 10/2020
1	Congenital Disorders of Glycosylation 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Postpartum Hemorrhage 01/2020
1	Chronic Pain 11/2019
1	Protein C Deficiency 01/2018
1	Necrosis 01/2018
1	Inflammation (Inflammations) 12/2017
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2012
1	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 10/2012

Drug/Important Bio-Agent (IBA)

6	AnticoagulantsIBA 01/2023 - 10/2020
4	Thrombin FDA Link 10/2020 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2017
3	Warfarin (Coumadin)FDA LinkGeneric 01/2023 - 01/2018
3	von Willebrand FactorIBA 01/2022 - 01/2020
2	emicizumabIBA 11/2023 - 01/2021
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2022 - 07/2013
2	Enoxaparin (Lovenox)FDA LinkGeneric 01/2022 - 10/2020
2	RivaroxabanIBA 10/2020 - 01/2018
1	Immunoglobulin G (IgG)IBA 01/2024
1	Antiphospholipid AntibodiesIBA 01/2024
1	Immunoglobulin M (IgM)IBA 01/2024
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2024
1	Glycoproteins (Glycoprotein)IBA 01/2024
1	Prothrombin (Factor II)IBA 01/2024
1	PhosphatidylserinesIBA 01/2024
1	Factor VIII (Coagulation Factor VIII)IBA 11/2023
1	Ferritins (Ferritin)IBA 01/2022
1	Progesterone FDA LinkGeneric 01/2022
1	TESIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2020
1	fibrin fragment D (D-dimer)IBA 11/2020
1	Vitamin K FDA Link 10/2020
1	Hydroxyurea (Hydrea)FDA LinkGeneric 10/2020
1	GlycolipidsIBA 01/2020
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2020
1	LipopolysaccharidesIBA 01/2020
1	AntithrombinsIBA 01/2020
1	Opioid Analgesics (Opioids)IBA 11/2019
1	Analgesics (Analgesic Drugs)IBA 11/2019
1	Hemoglobins (Hemoglobin)IBA 03/2019
1	Glutathione (Reduced Glutathione)IBA 10/2016
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 10/2016
1	AntioxidantsIBA 10/2016
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 10/2016
1	Estrogens (Estrogen)FDA Link 08/2015
1	Oral ContraceptivesIBA 08/2015
1	Protein SIBA 08/2015
1	Estrogen ReceptorsIBA 08/2015
1	Intrinsic Factor FDA Link 10/2012

Therapy/Procedure

4	Therapeutics 01/2021 - 07/2013
3	Central Venous Catheters 01/2022 - 07/2013
1	Intrauterine Devices (Intrauterine Device) 12/2022
1	Duration of Therapy 11/2022
1	Critical Care (Surgical Intensive Care) 11/2020
1	Contraindications 11/2020
1	Analgesia 11/2019
1	Pain Management 11/2019
1	Extracorporeal Membrane Oxygenation 03/2019